Eli Lilly Sales Increase Amid Surge for Weight Loss Drugs
Eli Lilly sales increase has caught the attention of Wall Street as the pharmaceutical giant reports a staggering 45% revenue growth driven by the surging demand for its weight loss drug, Zepbound, and diabetes treatment, Mounjaro.The company’s impressive earnings surpassed analysts’ expectations, highlighting its strong position in the burgeoning weight loss drug sales market.
Eli Lilly Sales Increase Amid Surge for Weight Loss Drugs Read More »